Metraipolis › archive › dc_db6892754e07

Limosilactobacillusreuteri Urob-7 Alleviates Hyperuricemia by Modulating Uric Acid Metabolism Through Nucleoside Degradation and Xanthine Oxidase Inhibition — Europe PMC PMID:41227678

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41227678
DOI
10.3390/foods14213706
License (as archived)
solo-consultazione
Archived
2026-11-08T22:46:32.787Z
SHA-256 of the archived text
fea1ef1719307c49666e1bbde90a69440ac294c7887f94228e5b37c16f4ae331
Stable URL of this page
https://metraipolis.com/documento/dc_db6892754e07

How to cite

Limosilactobacillusreuteri Urob-7 Alleviates Hyperuricemia by Modulating Uric Acid Metabolism Through Nucleoside Degradation and Xanthine Oxidase Inhibition — Europe PMC PMID:41227678 — Europe PMC (en), https://europepmc.org/article/MED/41227678 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db6892754e07 (Metraipolis archive dc_db6892754e07, sha256 fea1ef1719307c49666e1bbde90a69440ac294c7887f94228e5b37c16f4ae331)
BibTeX
@misc{dcdb6892754e07,
  title = {Limosilactobacillusreuteri Urob-7 Alleviates Hyperuricemia by Modulating Uric Acid Metabolism Through Nucleoside Degradation and Xanthine Oxidase Inhibition — Europe PMC PMID:41227678},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41227678},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db6892754e07; sha256 fea1ef1719307c49666e1bbde90a69440ac294c7887f94228e5b37c16f4ae331},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41227678. Agents can read the archived copy with the MCP tool read_document.